DES MOINES, Iowa — Kemin Industries will launch its MEFLUVAC H5 PLUS 8 vaccine in partnership with ilender in Latin America to assist in building immunity against the highly pathogenic avian influenza.
Kemin Biologics, the global veterinary vaccine division of Kemin, debuted the new vaccine at an event in Peru on Oct. 30 in the cities of Lima, Trujillo and Chincha. At this event, policy and distribution stakeholders, along with customers from the poultry meat and layer industries, gathered to discuss vaccinology and risk management programs. The industry leaders focused on the importance of addressing major pathogens that compromise animal performance. . .